Clik here to view.
Presbia to Participate in the 2016 Australasian Society of Cataract and...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that it will participate in the 20th Annual Australasian Society of Cataract and...
View ArticleClik here to view.
投资于癌症治愈方法：GE凭借收购Biosafe Group SA，致力于引领细胞疗法行业的产业化
英格兰CHALFONT ST GILES (美国商业资讯) — GE医疗集团已收购了Biosafe Group SA，后者是面向快速生长细胞疗法和再生医学行业的整合型细胞生物处理系统的提供商，该收购的金额未披露。收购Biosafe可壮大GE医疗集团面向细胞疗法客户的产品、解决方案和服务的端到端生态系统，并将GE的技术触角延伸到若干新的细胞和治疗类别。 Smart News...
View ArticleClik here to view.
Increase of Myopia and Ageing Population Will Boost Global Eyewear Sales to...
SINGAPORE Market Research Company Euromonitor International released today new data on the global eyewear industry. According to the new research, global sales of eyewear are forecast to reach...
View ArticleClik here to view.
Clik here to view.
Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally...
LEWISVILLE, Texas Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare...
View ArticleClik here to view.
Acelity to Offer New Gelling Fiber Advanced Wound Dressing
SAN ANTONIO Acelity, a global advanced wound care and regenerative medicine company, announced today that BIOSORB™ Gelling Fiber Dressing is now available in the United States and has Conformité...
View ArticleClik here to view.
Second Sight Announces Two Exclusive Distribution Agreements to Bring the...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful...
View ArticleClik here to view.
Clik here to view.
Hoya Reports First Quarter Financial Results
TOKYO HOYA Corporation (TOKYO: 7741) today announced financial results for the first quarter ended June 30, 2016. During the quarter, revenues totaled 115,165 million yen, representing a decline of...
View ArticleClik here to view.
Ligand Announces Multi-Program LTP Technology Licensing Agreement with...
SAN DIEGO Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion...
View ArticleClik here to view.
Central Orthodontic Clinic: Revolution in Orthodontics Accomplished with KILBON
SEOUL, South Korea KILBON, so-called next-generation orthodontics has recently become the hottest issue as it is very innovative to correct severe dentoalveolar protrusion and hyperdivergent face at...
View ArticleClik here to view.
SoftBank Launches Second Round of ‘SoftBank Innovation Program’
TOKYO SoftBank Corp. (“SoftBank”), a subsidiary of SoftBank Group Corp. (TOKYO:9984), today announced that it launched a second round for its ‘SoftBank Innovation Program’, a program that seeks a...
View ArticleClik here to view.
Nativis, Inc. Enters into Evaluation Agreement with Major Japan-Based...
SEATTLE Nativis, Inc., a clinical stage life sciences company developing non-invasive, medical device therapies for cancers and other serious diseases, today announced that it has entered into an...
View ArticleClik here to view.
Osprey Medical Announces Oversubscribed A$28 Million Private Placement
MINNEAPOLIS & MELBOURNE, Australia Osprey Medical, Inc. (ASX:OSP) (Osprey or Company) today announces that it has received commitments from sophisticated and institutional investors to subscribe...
View ArticleClik here to view.
NCCNガイドラインでオプチューンが初発膠芽腫の標準的治療の選択肢として推奨される
ジャージー島セントへリア （ビジネスワイヤ） — ノボキュア社（NASDAQ: NVCR）は本日、全米総合がん情報ネットワーク（NCCN）が中枢神経系がんの腫瘍診療ガイドライン（NCCNガイドライン）で、オプチューンを初発膠芽腫（GBM）の標準的治療の選択肢として推奨したと発表しました。...
View ArticleClik here to view.
Masimo宣布儿科O3™ 局部氧饱和度仪获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，配置O3儿科传感器的O3™ 局部氧饱和度仪的儿科适应证获得CE标记。局部氧饱和度仪也被称为组织或脑氧饱和度仪，可帮助临床医生监测脑氧合状况。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
昆泰与DaVita临床研究宣布缔结战略联盟
北卡罗莱纳州研究三角园区和明尼阿波利斯 (美国商业资讯) — 世界最大的产品开发和整合医疗保健服务提供商昆泰和肾脏医护领域的领先者DaVita HealthCare Partners Inc.的全资子公司DaVita临床研究(DaVita Clinical...
View ArticleClik here to view.
マシモが小児用O3™リージョナルオキシメトリーのCEマーク取得を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、小児用O3センサーを備えたO3™リージョナルオキシメトリーの小児適応に対するCEマーク取得を発表しました。組織オキシメトリーまたは脳オキシメトリーとも呼ばれるリージョナルオキシメトリーは、臨床医が脳酸素化状態をモニタリングするのに役立ちます。 このSmart News...
View ArticleClik here to view.
Clik here to view.
Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens™ surgeries performed on...
View Article